Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Hepatitis

Syringe services in limbo under Trump, risking hepatitis C progress

A decade after Congress first allowed federal funding to support clean needle programs, the Trump administration is backing off that policy, potentially risking progress made against hepatitis C, a deadly but curable virus mostly spread by people who inject drugs. The administration now says funding can no longer support programs such as…

Roll Call

If You Have Chronic Hepatitis B, a New FDA Approval Means You Should Ask About This Dangerous Co-Infection

A new FDA approval for Hepatitis Delta treatment means chronic hepatitis B patients should now ask about HDV testing. Here's why testing matters more than ever and who should ask.

Medical Daily

The FDA Approves the First-Ever Hepatitis Delta Treatment: Here's Why Hepatitis B Patients Should Get Tested

FDA approved bulevirtide May 22, 2026 — the first-ever Hepatitis Delta treatment. About 80,000 Americans have HDV. Here's who should ask for testing and what the approval means.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives

Liver cancer is one of the fastest rising causes of cancer-related deaths in the UK, and the third leading cause of cancer deaths worldwide.

The Conversation

Hepatitis Delta Is the Deadliest Form of Viral Hepatitis — and the U.S. Just Got Its First Treatment for It

FDA granted accelerated approval to Hepcludex (bulevirtide) for Hepatitis Delta on May 22, 2026 — the first-ever U.S. treatment for HDV. What patients need to know.

Medical Daily

7 Vaccines Doctors Recommend for Adults Over 50

Turning 50 often comes with new priorities, and protecting your health moves higher on the list. While many people focus on exercise, diet, and preventive...

Saving Advice

Hepatitis A Outbreak in Canada Leaves 4 Dead, 142 Hospitalized; CDC Issues Travel Notice as Many Americans Traveling to Canada Remain Unvaccinated.

The CDC issued a hepatitis A travel notice for Manitoba, Canada on June 4, 2026. The outbreak has grown to 658 cases, 142 hospitalizations, and 4 deaths since April 2025. Winnipeg restaurant exposures have been identified. Here is what U.S. travelers need to know before visiting Canada.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

San Diego's Unhoused Population Faces Simultaneous Hepatitis A and Mpox Threats — Health Officials Urgently Expanding Vaccination Access

San Diego health officials are escalating vaccination efforts as hepatitis A and mpox cases rise simultaneously among the city's large unhoused population. Officials report cases in downtown encampments.

Medical Daily

FDA Warns New Yorkers: Hepatitis A Linked to Frozen Blood Clams Sold in New York State — Illnesses Span Months

The FDA issued a public alert about hepatitis A-linked blood clams distributed in New York. Cases traced to La Serranita frozen blood clams imported from Ecuador. First illness reported in July 2025.

Medical Daily

The U.S. Was on Track to Eliminate Hepatitis C by 2030 — Then Came the Federal Public Health Cuts That Are Dismantling the Programs Doing It

Federal public health cuts are jeopardizing hepatitis C elimination programs in California, putting testing and curative treatment access at risk.

Medical Daily

Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead

Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming decisions tied to its herpes simplex virus type 2 program, expansion of its hepatitis delta candidate

MarketBeat

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands

Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex virus programs while advancing ABI-6250 into multiple liver disease indications, Chief Executive Officer Jason Okazaki said during a Jefferies biotech event. Okazaki said 2024 w

MarketBeat

What killed Beethoven? His own DNA finally answered after 200 years, with a bombshell twist

A groundbreaking genetic study has provided new insights into the life and death of composer Ludwig van Beethoven nearly 200 years after his passing. Researchers analyzed DNA from authenticated hair samples and found evidence of inherited liver disease risk factors and a hepatitis B infection that may have contributed to…

The Economic Times

First-in-Class Hepatitis B Drug Shows Promise for 'Functional Cure' in Early Trials

An experimental new treatment for chronic hepatitis B is raising hopes for what researchers call a potential "functional cure," a milestone that could change how the viral liver disease is managed in the future.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

Experimental hepatitis B drug may offer 'functional cure' for some patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

The Economic Times

GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studies

GSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achieving a functional cure after six months of treatment. This offers a potential finite treatment course, a significant advancement over lifelong antiviral pills for the over 250 million people globally living with…

AAP

Experimental hepatitis B drug might offer 'functional cure' for a subset of patients

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

The Independent UK

FDA fast-tracks promising hepatitis B drug after ‘remarkable’ trial results

New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance

Mirum Pharmaceuticals (NASDAQ:MIRM) executives said the rare disease company is entering a catalyst-heavy period, with recent positive clinical updates, ongoing commercial momentum for LIVMARLI and additional business development activity expanding its portfolio. Speaking at RBC Capital Markets’ 20

The Conversation

How a remarkable trial on bedrest during the Korean war helped lead to evidence-based medicine

In 1959, a young doctor named David Sackett stumbled on a clinical trial that would change his life – and most of ours. The study showed that conventional wisdom on bed rest in medicine was wrong. And it helped lead Sackett and others to develop evidence-based medicine, in which doctors…

Evening Standard

Burnham criticises Government over ‘dividing lines’ in blood scandal payouts

A memorial service for those affected was held at St Paul’s Cathedral in London, with Prime Minister Sir Keir Starmer attending.

Evening Standard

UK must ‘always remember’ those affected by infected blood scandal

A memorial service for those affected was held at St Paul’s Cathedral in London.

Roll Call

US overlooks drug treatment centers in hepatitis C fight

MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for hepatitis C, especially those who are unhoused or actively using drugs. Starkie, an intervention worker for a drug treatment service, recalled the difficulty of treating a man living in a tent…

MarketBeat

Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference

Assembly Biosciences (NASDAQ:ASMB) Chief Medical Officer Anuj Gaggar outlined the company’s virology strategy and upcoming clinical priorities during a Bank of America-hosted discussion, emphasizing programs in herpes simplex virus, hepatitis D and transplant-related herpes viruses. Gaggar describe

The Guardian - AU

Health alert issued urging thousands of patients of retired Sydney dentist to get tested for HIV and hepatitis

Health official says thousands of people may be affected due to ‘poor infection control practices’ at Strathfield clinic

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Infected Blood Inquiry

35 stories

IBCA

25 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.